which increased prices due to the drought. Operators are not expected to significantly increase prices and focus mainly on controlling cost, due to the economic slowdown and highly competitive market
3Q22, the cost of service was at Bt21,863mn, increased 2.0% YoY and 1.1% QoQ mainly from the increase in network OPEX due to rising of utility cost. • Regulatory fee was at Bt1,380mn, increased 1.9% YoY
3Q22, the cost of service was at Bt21,863mn, increased 2.0% YoY and 1.1% QoQ mainly from the increase in network OPEX due to rising of utility cost. • Regulatory fee was at Bt1,380mn, increased 1.9% YoY
3Q22, the cost of service was at Bt21,863mn, increased 2.0% YoY and 1.1% QoQ mainly from the increase in network OPEX due to rising of utility cost. • Regulatory fee was at Bt1,380mn, increased 1.9% YoY
quarter driven by resilient sales and margins in Integrated PET, USA PX and PIA businesses. Core net profit grew to THB 1.6B • Core EBITDA grew in all segments and in all regions as our products primarily
world economic growth and the customer's sales growth. reviewQ419.xlsx MD&A 2019 24/02/2020 The groups sales revenue are in foreign currency (primarily USD) and USD currency costs are approximately 60
customer's sales growth. The groups sales revenue are in foreign currency (primarily USD) and USD currency costs are approximately 60% percent of sales revenues. The Group operating profit sensitivity to
baht which represent gross profit margin of 58.8%. An increasing of gross profit primarily stem from an increasing of gross profit proportion in revenues increase from collection of purchased accounted
to be temporary. As well, economy of developing countries in Asia still enables to be well expanded by mainly receiving supportive factors from recovery of domestic demand, which includes a direction
86 million (or 53%), increasing in services of THB 11 million (or 47%) from Q2/2017, increasing in revenue from sales mainly came from Distributor of medical devices and equipment. The Company and its